Clinical Presentation & Protocol
Patient Usually Complains Of
Patient presents with a history of recurrent abdominal pain, typically localized to the left lower quadrant, associated with altered bowel habits, including hematochezia and increased stool frequency. Symptoms are noted in the setting of known colonic diverticulosis. No systemic symptoms such as fever, significant weight loss, or nocturnal diarrhea reported. Symptoms are intermittent and lack the classic features of inflammatory bowel disease (IBD).
Clinical Examination Findings
Abdominal examination reveals mild tenderness to deep palpation in the left lower quadrant. No evidence of rebound tenderness, guarding, or rigidity. Bowel sounds are present and normoactive. Digital rectal examination shows no masses or fissures, with guaiac-positive stool noted. No signs of peritonitis or abdominal distension.
Treatment Protocol
Initial management includes a trial of 5-aminosalicylic acid (5-ASA) agents or topical mesalamine for symptomatic relief. Antibiotic therapy (e.g., ciprofloxacin and metronidazole) may be indicated if there is suspicion of bacterial overgrowth or associated diverticulitis. Dietary modifications including high-fiber intake are recommended. Follow-up colonoscopy is scheduled to monitor mucosal healing and rule out IBD or malignancy.
1. Comprehensive Executive Overview
Segmental Colitis Associated with Diverticulosis (SCAD) is a distinct clinical entity characterized by chronic inflammation of the colonic mucosa confined to segments affected by diverticulosis, while sparing the rectum and the proximal colon. Although SCAD shares certain histological and clinical features with Inflammatory Bowel Disease (IBD)โspecifically Ulcerative Colitis (UC)โit is considered a separate pathological condition with a significantly more favorable prognosis.
In clinical gastroenterology, SCAD is often underdiagnosed or misdiagnosed as IBD. The critical distinction lies in the localization: SCAD involves the diverticular segments (most commonly the sigmoid colon) with rectal sparing. Given the prevalence of diverticular disease in aging populations, understanding SCAD is vital for gastroenterologists and patients alike to avoid unnecessary long-term immunosuppressive therapies.
2. Detailed Pathophysiology, Etiology, and Risk Factors
The exact etiology of SCAD remains multifactorial and is currently a subject of intense clinical research. Unlike Ulcerative Colitis, which is primarily an autoimmune-mediated disorder, SCAD is thought to arise from a complex interplay of localized mechanical, vascular, and microbial factors.
Pathophysiological Mechanisms
- Mucosal Ischemia: The proximity of diverticula to the vasa recta (the small arteries supplying the colon) suggests that chronic, low-grade ischemia may trigger an inflammatory response in the inter-diverticular mucosa.
- Fecal Stasis: Diverticula are prone to fecal impaction. The prolonged contact between stagnant fecal matter and the colonic mucosa can disrupt the protective mucus barrier, allowing bacterial translocation and subsequent inflammation.
- Microbiome Dysbiosis: Alterations in the gut microbiota within the diverticular pockets may lead to an overgrowth of pro-inflammatory bacteria, triggering the host immune system.
- Bile Acid Malabsorption: Some evidence suggests that altered bile acid metabolism in the sigmoid colon may play a role in inducing mucosal irritation.
Risk Factors
| Risk Factor | Clinical Relevance |
|---|---|
| Age | Most common in patients aged 60โ80 years. |
| Anatomical Distribution | Presence of diverticulosis in the sigmoid colon. |
| Chronic Constipation | Increases intraluminal pressure and fecal stasis. |
| NSAID Use | Non-steroidal anti-inflammatory drugs can exacerbate mucosal injury. |
| Obesity | Associated with systemic low-grade inflammation. |
3. Signs, Symptoms, and Clinical Presentation
SCAD presents with a clinical picture that frequently mimics idiopathic IBD, leading to initial diagnostic confusion. The symptoms are generally chronic and intermittent rather than acute and fulminant.
Common Clinical Manifestations:
- Hematochezia: Bright red blood per rectum is the most common presenting symptom, often occurring during bowel movements.
- Abdominal Pain: Usually localized to the left lower quadrant (LLQ), often described as cramping or aching.
- Altered Bowel Habits: Patients may report increased frequency of stools or episodes of urgency.
- Tenesmus: A sensation of incomplete evacuation, though less common than in UC.
- Absence of Systemic Symptoms: Unlike severe IBD, SCAD patients rarely present with significant fever, weight loss, or extra-intestinal manifestations (such as uveitis or arthritis).
4. Standard Diagnostic Evaluation & Workup
The diagnosis of SCAD is a diagnosis of exclusion. It requires a systematic approach to rule out IBD, ischemic colitis, and malignancy.
Gold Standard Diagnostic Criteria:
- Colonoscopy with Biopsy: This is the primary diagnostic tool. The endoscopic appearance typically shows inflammation (erythema, friability, ulceration) specifically in the segments with diverticula, while the rectum is notably spared.
- Histopathological Analysis: Biopsies must be taken from both the inflamed segments and the unaffected mucosa. Histology typically reveals chronic active colitis with crypt distortion or abscesses. Importantly, the absence of granulomas helps rule out Crohnโs disease.
- Imaging (CT Enterography or Colonography): Used to assess the extent of diverticulosis and to rule out complications such as diverticular abscesses or fistulas.
Diagnostic Workup Table
- Laboratory Assays: CBC (to check for anemia), CRP/ESR (to assess inflammation), and Fecal Calprotectin.
- Stool Studies: Necessary to rule out infectious etiologies (e.g., C. difficile toxins, bacterial cultures).
- Endoscopic Assessment: Must confirm the absence of rectal involvement (a key differentiator from UC).
5. Therapeutic Interventions
Management of SCAD is highly effective, and most patients achieve long-term remission with conservative therapy. The treatment approach is stratified based on symptom severity.
Pharmacotherapy
- 5-Aminosalicylic Acid (5-ASA): Mesalamine is the first-line treatment for SCAD. Oral or topical formulations (suppositories/enemas) are used to induce mucosal healing.
- Antibiotics: In cases where bacterial overgrowth is suspected, short courses of antibiotics (e.g., Ciprofloxacin or Metronidazole) may be used adjunctively.
- Corticosteroids: Rarely required. If used, they are reserved for short-term control of severe symptoms and are tapered rapidly.
Lifestyle and Surgical Management
- Dietary Modification: A high-fiber diet is recommended to improve transit time and reduce intraluminal pressure, provided the patient is not in an acute, obstructive phase.
- Hydration: Ensuring adequate fluid intake to prevent constipation.
- Surgical Intervention: Surgery is reserved for patients who are refractory to medical therapy, develop recurrent massive bleeding, or suffer from complications like strictures or fistulas. The standard procedure is a segmental colectomy.
6. Frequently Asked Questions (FAQ)
1. Is SCAD the same as Ulcerative Colitis?
No. While they share symptoms, SCAD is localized to diverticular segments and spares the rectum, whereas UC typically involves the rectum and progresses proximally.
2. Can SCAD lead to colon cancer?
Current evidence suggests that SCAD does not carry the same increased risk of colorectal cancer as long-standing, extensive Ulcerative Colitis.
3. Will I need surgery for SCAD?
Most patients respond well to medical therapy (like Mesalamine). Surgery is only considered for patients who do not respond to medication or develop chronic, severe complications.
4. What is the role of diet in managing SCAD?
A high-fiber diet is generally recommended to prevent constipation. However, during an acute flare, a low-residue diet may be temporarily advised.
5. Is SCAD a lifelong condition?
It is a chronic condition that may have periods of remission and flares. However, with proper management, many patients lead symptom-free lives.
6. Does SCAD cause systemic symptoms like weight loss?
Systemic symptoms are rare in SCAD. If you experience significant weight loss, your doctor will likely investigate other conditions, such as Crohn's disease or malignancy.
7. How often should I have a colonoscopy?
Your gastroenterologist will determine the frequency based on your symptoms and the severity of the initial inflammation. Typically, surveillance is less frequent than in IBD.
8. Are there specific medications I should avoid?
NSAIDs (like Ibuprofen or Naproxen) can irritate the colonic mucosa and may exacerbate SCAD symptoms. Consult your doctor for safer pain management alternatives.
9. Can SCAD be cured?
While there is no "cure" that eliminates the underlying diverticulosis, SCAD can be effectively managed, and long-term remission is the standard goal of treatment.
10. Does SCAD affect the small intestine?
No. SCAD is strictly a condition of the colon (large intestine). It does not involve the small bowel.
Disclaimer: This guide is for educational purposes only and does not constitute medical advice. Always consult with a board-certified gastroenterologist for diagnosis and treatment plans tailored to your specific clinical history.